Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran

NCT00757679 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

153

Enrollment

INDUSTRY

Sponsor class

Conditions

Fibromyalgia Syndrome

Interventions

DRUG: Milnacipran
DRUG: Placebo

Sponsor

Pierre Fabre Medicament